GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $123,002,000 | -12.5% | 2,825,692 | -12.5% | 0.03% | +25.0% |
Q1 2022 | $140,601,000 | -62.5% | 3,227,742 | -62.0% | 0.02% | +118.2% |
Q4 2021 | $374,982,000 | +170.6% | 8,502,940 | +134.5% | 0.01% | -38.9% |
Q3 2021 | $138,553,000 | +15.2% | 3,626,099 | +20.1% | 0.02% | +12.5% |
Q2 2021 | $120,266,000 | -4.7% | 3,020,245 | -14.6% | 0.02% | -15.8% |
Q1 2021 | $126,198,000 | -51.7% | 3,535,940 | -50.2% | 0.02% | -9.5% |
Q4 2020 | $261,054,000 | +217.8% | 7,093,834 | +225.1% | 0.02% | +31.2% |
Q3 2020 | $82,137,000 | +1.7% | 2,182,173 | +10.2% | 0.02% | -15.8% |
Q2 2020 | $80,790,000 | +15.4% | 1,980,637 | +7.2% | 0.02% | -13.6% |
Q1 2020 | $70,004,000 | -46.0% | 1,847,562 | -33.1% | 0.02% | -40.5% |
Q4 2019 | $129,697,000 | +3.2% | 2,760,100 | -6.3% | 0.04% | -11.9% |
Q3 2019 | $125,729,000 | -54.7% | 2,945,815 | -57.5% | 0.04% | +23.5% |
Q2 2019 | $277,411,000 | +182.1% | 6,931,798 | +194.6% | 0.03% | -15.0% |
Q1 2019 | $98,339,000 | +9.1% | 2,353,176 | -0.2% | 0.04% | +11.1% |
Q4 2018 | $90,132,000 | +13.8% | 2,358,859 | +19.6% | 0.04% | +38.5% |
Q3 2018 | $79,218,000 | -4.5% | 1,972,081 | -4.2% | 0.03% | -7.1% |
Q2 2018 | $82,974,000 | -42.3% | 2,058,400 | -44.0% | 0.03% | -46.2% |
Q1 2018 | $143,682,000 | +23.0% | 3,677,561 | +11.7% | 0.05% | +26.8% |
Q4 2017 | $116,774,000 | +21.3% | 3,292,196 | +38.8% | 0.04% | +10.8% |
Q3 2017 | $96,278,000 | +1.5% | 2,371,387 | +7.8% | 0.04% | -11.9% |
Q2 2017 | $94,838,000 | -16.9% | 2,199,400 | -18.7% | 0.04% | -27.6% |
Q1 2017 | $114,104,000 | -13.4% | 2,706,456 | -20.9% | 0.06% | -12.1% |
Q4 2016 | $131,718,000 | -9.8% | 3,420,341 | +1.0% | 0.07% | -5.7% |
Q3 2016 | $145,991,000 | +8.4% | 3,384,900 | +8.9% | 0.07% | -4.1% |
Q2 2016 | $134,666,000 | +0.7% | 3,107,198 | -5.8% | 0.07% | +2.8% |
Q1 2016 | $133,694,000 | -4.9% | 3,297,019 | -5.4% | 0.07% | +9.2% |
Q4 2015 | $140,643,000 | -22.8% | 3,485,583 | -26.4% | 0.06% | -16.7% |
Q3 2015 | $182,119,000 | +11.2% | 4,736,530 | +20.4% | 0.08% | +11.4% |
Q2 2015 | $163,833,000 | +26.0% | 3,933,559 | +39.6% | 0.07% | +18.6% |
Q1 2015 | $130,065,000 | -19.5% | 2,818,317 | -25.5% | 0.06% | -9.2% |
Q4 2014 | $161,583,000 | -8.6% | 3,780,598 | -1.7% | 0.06% | -4.4% |
Q3 2014 | $176,782,000 | +111.1% | 3,845,581 | +145.6% | 0.07% | +88.9% |
Q2 2014 | $83,738,000 | +29.8% | 1,565,781 | +29.6% | 0.04% | +20.0% |
Q1 2014 | $64,535,000 | +24.9% | 1,207,852 | +24.8% | 0.03% | +25.0% |
Q4 2013 | $51,664,000 | -19.6% | 967,703 | -24.4% | 0.02% | -29.4% |
Q3 2013 | $64,239,000 | +26.7% | 1,280,417 | +26.2% | 0.03% | +17.2% |
Q2 2013 | $50,709,000 | – | 1,014,810 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |